Collegium Pharmaceutical Inc (COLL) — Net Asset Quality Index
Collegium Pharmaceutical Inc (COLL) has a Net Asset Quality Index of 17.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.61 Billion minus total liabilities of $1.33 Billion yields net assets of $274.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read COLL total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Collegium Pharmaceutical Inc Net Asset Quality Index Over Time (2013–2024)
This chart shows how Collegium Pharmaceutical Inc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 17.1%, representing net assets of $274.81 Million against total assets of $1.61 Billion USD. For live market cap and overall valuation, see market value of Collegium Pharmaceutical Inc.
Annual Net Asset Quality Index for Collegium Pharmaceutical Inc (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check COLL PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 13.8% | $228.84 Million | $1.66 Billion | $1.43 Billion | ▼ -3.3 pp |
| 2023 | 17.1% | $195.43 Million | $1.14 Billion | $947.88 Million | ▲ +0.5 pp |
| 2022 | 16.6% | $194.84 Million | $1.17 Billion | $979.29 Million | ▼ -12.7 pp |
| 2021 | 29.3% | $202.93 Million | $692.08 Million | $489.15 Million | ▲ +0.4 pp |
| 2020 | 28.9% | $186.03 Million | $643.84 Million | $457.81 Million | ▲ +0.3 pp |
| 2019 | 28.5% | $87.43 Million | $306.30 Million | $218.87 Million | ▼ -2.9 pp |
| 2018 | 31.4% | $91.58 Million | $291.25 Million | $199.66 Million | ▼ -45.3 pp |
| 2017 | 76.8% | $104.08 Million | $135.57 Million | $31.49 Million | ▼ -6.5 pp |
| 2016 | 83.3% | $134.91 Million | $162.02 Million | $27.11 Million | ▼ -3.8 pp |
| 2015 | 87.1% | $85.07 Million | $97.72 Million | $12.65 Million | ▲ +327.5 pp |
| 2014 | -240.5% | $-12.24 Million | $5.09 Million | $17.33 Million | ▼ -302.3 pp |
| 2013 | 61.8% | $5.58 Million | $9.03 Million | $3.45 Million | — |